FVIIa Sales to Skyrocket? A lower price will encourage use in acquired hemophilia, trauma, and other acute-care settings. The forecasts in this chart are actually conservative because they exclude potential use as a prophylaxis.
Source: DataMonitor
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”